 |
인쇄하기
취소
|
Crystal Genomics not to acquire BexPharm Korea
Crystal Genomics and BexPharm Korea has recently agreed not to proceed any merger and acquisition (M&A) between both companies.
Crystal Genomics announced the M&A plan with BexPharm last May with a strong interest and determination to acquire the latter, anticipating the increase of synergy.
CrystalGenomics has established several drug discovery collaborations with leading pharmaceutical ...
Crystal Genomics announced the M&A plan with BexPharm last May with a strong interest and determination to acquire the latter, anticipating the increase of synergy.
CrystalGenomics has established several drug discovery collaborations with leading pharmaceutical ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.